Question 1

What are the most cited papers from SilaGene (United States)?

Accepted Answer

The most cited paper from SilaGene (United States) is "Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death" (Jin Hyang Song, Hyun-Jin Kang, Libia A. Luevano et al., 2019), with 58 citations. Next come "U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo" (7) and "Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma" (5).

Question 2

Which research topics does SilaGene (United States) publish most on?

Accepted Answer

By volume in 2022-now: Microtubule and mitosis dynamics, Glioma Diagnosis and Treatment, Brain Metastases and Treatment and Cancer therapeutics and mechanisms.

Question 3

Which fields of science does SilaGene (United States) work in?

Accepted Answer

In all years, 85% of research at SilaGene (United States) is in Life Sciences, 15% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (79%), Medicine (15%), Pharmacology, Toxicology and Pharmaceutics (6%). It does 1.7× the world's share of Life Sciences.

Question 4

Is SilaGene (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 279% higher than in 2018-2021.